(Q34003496)

30 July 2017

1 reference

title

Ductal carcinoma in situ. Implications for screening mammography (English)

1 reference

30 July 2017

1 reference

Feig SA

1

1 reference

30 July 2017

1 July 2000

1 reference

Radiologic Clinics of North America

30 July 2017

1 reference

30 July 2017

38

1 reference

30 July 2017

4

1 reference

30 July 2017

653-68, vii

1 reference

Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The prevalence of carcinoma in situ in normal and cancer-associated breasts

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

c-erbB-2 oncogene in breast cancer: the right target or a decoy?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Follow-up of two treatment modalities for ductal cancer in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Proceedings: A clinicopathologic study of atypical lesions of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Breast Cancer Detection Demonstration Project: five-year summary report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Potential value of hormone receptor assay in carcinoma in situ of breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Results of treating ductal carcinomaIn situ of the breast with conservative surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Intraductal "Noninfiltrating" Carcinoma of the Breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Estrogen receptor immunohistochemistry in carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

How to prevent invasive breast cancer: detect and excise duct carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Mutations in human breast cancer: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Management of screen detected ductal carcinoma in situ of the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Family history and bilateral primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

p53 alterations in all stages of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The neu-protein and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The p53 tumor suppressor gene in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Prognostic factors of breast neoplasms detected on screening by mammography and physical examination

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Early phases in the development of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The study of mammary carcinoma by mammography and whole organ sectioningearly observations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Treatment of intraductal carcinoma with limited surgery: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Atypical epithelial hyperplasia associated with breast cancer and fibrocystic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Mammary duct proliferation in the elderly. A histopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Conservation therapy for breast cancers other than infiltrating ductal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Breast conservation therapy for intraductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Genomic alterations in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: pathologic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Molecular genetic studies of early breast cancer evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Ductal carcinoma in situ of the breast: understanding the misunderstood stepchild

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Heterogeneity of intraductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Occult breast cancer: prevalence and radiographic detectability

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Incidence of bilateral tumours in a population-based series of breast-cancer patients. I. Two approaches to an epidemiological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The contralateral breast at reconstructive surgery after breast cancer operation--a histopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

The clinical significance of pre-invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

p53 protein expression and nuclear DNA content in breast intraductal proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Ductal carcinoma in situ (intraductal carcinoma) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Survival experience in the Breast Cancer Detection Demonstration Project

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Evidence on screening for breast cancer from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Duct carcinoma in situ: 227 cases without microinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

A prognostic index for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

bcl-2 expression in the spectrum of preinvasive breast lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

American Cancer Society guidelines for the early detection of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Definitive irradiation for intraductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Loss of heterozygosity in ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

New Swedish breast cancer detection results for women aged 40-49

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Expression of p53 protein in infiltrating and in-situ breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Epidemiology of in situ and invasive breast cancer in women aged under 45.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

On the origin and progression of ductal carcinoma in the human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970192-5

7 January 2021

10.1016/S0033-8389(05)70192-5

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10943269